Skip to main content
SpringerLink
Log in

Imaging Neuroendocrine Hepatic Metastases Following 90Y-Radioembolization: Is It Time to Implement Routine Use of PET Molecular/Metabolic Probes?

  • Letter to the Editor
  • Published:
CardioVascular and Interventional Radiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Braat AJAT, Kappadath SC, Ahmadzadehfar H, et al. Radioembolization with 90Y resin microspheres of neuroendocrine liver metastases: international multicenter study on efficacy and toxicity. Cardiovasc Intervent Radiol. 2019;42(3):413–25. https://doi.org/10.1007/s00270-018-2148-0.

    Article  CAS  PubMed  Google Scholar 

  2. Joo I, Kim HC, Kim GM, Paeng JC. Imaging evaluation following 90Y radioembolization of liver tumours: what radiologists should know. Korean J Radiol. 2018;19(2):209–22.

    Article  PubMed  PubMed Central  Google Scholar 

  3. Velikyan I. Prospective of 68 Ga-radiopharmaceutical development. Theranostics. 2014;4(1):47–80.

    Article  CAS  Google Scholar 

  4. Filippi L, Scopinaro F, Pelle G, et al. Molecular response assessed by (68)Ga-DOTANOC and survival after (90)Y microsphere therapy in patients with liver metastases from neuroendocrine tumours. Eur J Nucl Med Mol Imaging. 2016;43(3):432–40.

    Article  CAS  PubMed  Google Scholar 

  5. Kayani I, Bomanji JB, Groves A, et al. Functional imaging of neuroendocrine tumors with combined PET/CT using 68 Ga-DOTATATE (DOTA-DPhe1, Tyr3-octreotate) and 18F-FDG. Cancer. 2008;112(11):2447–55.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Nuclear Medicine Unit, “Santa Maria Goretti” Hospital, via Canova, Latina, Italy

    Luca Filippi & Oreste Bagni

  2. Department of Biomedicine and Prevention, University Tor Vergata, Rome, Italy

    Orazio Schillaci

  3. IRCCS Neuromed, Pozzilli, Italy

    Orazio Schillaci

  4. Department of Interventional Radiology, S. Camillo Hospital, Rome, Italy

    Roberto Cianni

Authors
  1. Luca Filippi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Orazio Schillaci
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Roberto Cianni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Oreste Bagni
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Luca Filippi.

Ethics declarations

Conflict of interest

The authors declare that they have no conflicts of interest.

Ethical Approval

This article does not contain any studies with human participants or animals performed by any of the authors.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Filippi, L., Schillaci, O., Cianni, R. et al. Imaging Neuroendocrine Hepatic Metastases Following 90Y-Radioembolization: Is It Time to Implement Routine Use of PET Molecular/Metabolic Probes?. Cardiovasc Intervent Radiol 42, 933–934 (2019). https://doi.org/10.1007/s00270-019-02186-w

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00270-019-02186-w

Search

Navigation